Hydralazine Hydrochloride Tablet
Product Images NDC 50228-182

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Hydralazine Hydrochloride (NDC 50228-182). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sciegen Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (10 mg (1,000 Tablets Bottle))

Package Label-principal Display Panel (10 mg (1,000 Tablets Bottle))
Each tablet of this medicine contains 10 mg of hydralazine hydrochloride. The recommended dosage is dependent on the information provided along with the prescription. It should be stored at temperatures ranging from 20°C to 25°C and needs to be kept away from children in a tight light-resistant container. This medicine is produced by ScieGen Pharmaceuticals in Hauppaugs, NY. The NDC number for this product is 50228-182-10 and comes in packs of 1,000 tablets that require a prescription.*
FDA Label Image

Package Label-principal Display Panel (10 mg (100 Tablets Bottle))

Package Label-principal Display Panel (10 mg (100 Tablets Bottle))
Each tablet contains 10 mg of hydralazine hydrochloride. It is advised to read the accompanying prescribing information and store the medication in a tight, light-resistant container with a child-resistant closure. The manufacturer is ScieGen Pharmaceticas, Inc, located in Hauppauge, NY. This medication should be kept out of the reach of children. It is used as a prescription medicine.*
FDA Label Image

Package Label-principal Display Panel (100 mg (1,000 Tablets Bottle))

Package Label-principal Display Panel (100 mg (1,000 Tablets Bottle))
Each tablet contains 100 mg of hydralazine hydrochloride, used to treat high blood pressure. The dosage should be followed as per the accompanying prescription. The medicine should be stored at room temperature and dispensed in a tightly sealed, light-resistant container to maintain its quality. The manufacturer of the medicine is ScieGen Pharmaceuticals Inc., and the tablets are available in a bottle of 1000 tablets. NDC 50228-185-10 is the National Drug Code (NDC) for the medicine. Keep the medicine out of children's reach.*
FDA Label Image

Package Label-principal Display Panel (100 mg (100 Tablets Bottle))

Package Label-principal Display Panel (100 mg (100 Tablets Bottle))
Each tablet of HydrALAZINE Hydrochloride contains 100 mg of hydralazine hydrochloride, USP. The usual dosage should be read from the accompanying prescribing information. The tablets should be stored within the temperature range of 20°C to 25°C (68°F to 77°F) and excursions are permitted up to 15°C to 30°C (59°F to 86°F) as indicated by USP Controlled Room Temperatures. Dispensing should be done in a tight light-resistant container as defined by the USP along with a child-resistant closure as required. Keep this and all medications away from the reach of children. Manufactured by ScieGen Pharmaceuticals, Inc. Hauppaugs, NY 11783. NDC code 50228-185-01. This medication requires a prescription.*
FDA Label Image

Package Label-principal Display Panel (25 mg (1,000 Tablets Bottle))

Package Label-principal Display Panel (25 mg (1,000 Tablets Bottle))
Each tablet of Hydralazine Hydrochloride contains 25 mg of the active ingredient. It is important to read the prescribing information before taking this medication. It should be stored in a tightly closed container, protected from light, at room temperature (20° to 25°C or 68° to 77°F), with excursions permitted to 15° to 30°C (59° to 86°F) as specified in the USP. The container should also have a child-resistant closure. This medication should be kept out of reach of children. The manufacturer of this medication is SciaGen Pharmaceuticals, and it comes in a bottle of 1000 tablets. This medication requires a prescription to obtain.*
FDA Label Image

Package Label-principal Display Panel (25 mg (100 Tablets Bottle))

Package Label-principal Display Panel (25 mg (100 Tablets Bottle))
Each tablet contains 25 mg of hydralazine hydrochloride, USP. It is important to read the accompanying prescribing information and keep the medication out of reach of children. The tablets should be stored between 20-25°C (88-77°F) with excursions permitted to 15-30°C (59-86°F). The medication should be dispensed in a tight, light-resistant container with a child-resistant closure. This medication is manufactured by ScieGen Pharmaceuticals, Inc. in Hauppauge, NY and has an assigned National Drug Code (NDC) of 50228-183-01.*
FDA Label Image

Package Label-principal Display Panel (50 mg (1,000 Tablets Bottle))

FDA Label Image

Package Label-principal Display Panel (50 mg (100 Tablets Bottle))

Package Label-principal Display Panel (50 mg (100 Tablets Bottle))
Each tablet contains 50 mg of hydralazine hydrochloride, USP. It is a medication that requires a prescription and the usual dosage must be obtained from the accompanying prescribing information. It should be stored in a specific temperature range and in a tight, light-resistant container with a child-resistant closure. This medication should be kept out of reach of children. The manufacturer is ScieGen Pharmaceuticals, Inc. and it comes in a package containing 100 tablets.*
FDA Label Image

Chem Structure (Image 01)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.